The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated Macrophages

• Published in: BioMed research international Vol. 2013; no. 2013; pp. 1 - 15
• Main Authors: Alesse, Edoardo, Tessitore, Alessandra, Cicciarelli, Germana, Gaggiano, Agata, Verzella, Daniela, Fischietti, Mariafausta, Capece, Daria, Zazzeroni, Francesca
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Publishing Corporation 01.01.2013; John Wiley & Sons, Inc
• Subjects: Cancer cells; Carcinoma, Hepatocellular - genetics; Carcinoma, Hepatocellular - metabolism; Carcinoma, Hepatocellular - pathology; Cytokines - metabolism; Development and progression; Disease Progression; Hepatoma; Humans; Inflammation - genetics; Inflammation - metabolism; Inflammation - pathology; Leukocytes - metabolism; Leukocytes - pathology; Liver Neoplasms - genetics; Liver Neoplasms - metabolism; Liver Neoplasms - pathology; Macrophages; Macrophages - metabolism; Macrophages - pathology; NF-kappa B - metabolism; Physiological aspects; Review; Signal Transduction; Tumor Microenvironment; Italy
• ISSN: 2314-6133; 2314-6141
• DOI: 10.1155/2013/187204

Hepatocellular carcinoma (HCC) is one of the most common and aggressive human cancers worldwide. HCC is an example of inflammation-related cancer and represents a paradigm of the relation occurring between tumor microenvironment and tumor development. Tumor-associated macrophages (TAMs) are a major component of leukocyte infiltrate of tumors and play a pivotal role in tumor progression of inflammation-related cancer, including HCC. Several studies indicate that, in the tumor microenvironment, TAMs acquire an M2-polarized phenotype and promote angiogenesis, metastasis, and suppression of adaptive immunity through the expression of cytokines, chemokines, growth factors, and matrix metalloproteases. Indeed, an established M2 macrophage population has been associated with poor prognosis in HCC. The molecular links that connect cancer cells and TAMs are not completely known, but recent studies have demonstrated that NF-κB, STAT-3, and HIF-1 signaling pathways play key roles in this crosstalk. In this paper, we discuss the current knowledge about the role of TAMs in HCC development, highlighting the role of TAM-derived cytokines, chemokines, and growth factors in the initiation and progression of liver cancer and outlining the signaling pathways involved in the interplay between cancer cells and TAMs.